GSK US Medical Affairs

This page is sponsored by GSK Medical Affairs, is considered non-promotional, and is intended for US healthcare professionals only.

 

Asthma
18:27

GSK US Medical Affairs

Asthma Drivers of Disease: The Effects of IL-5 on Eosinophils and Other Cell Types that Contribute to Airway remodeling and Disease Progression

FEATURING Geoffrey Chupp
  • 6 views
  • January 21, 2025
04:57

GSK US Medical Affairs

Transforming Severe Asthma Management: Targeting IL-5 for Sustained Disease Control

FEATURING Diego J. Maselli
  • December 16, 2025
05:26

GSK US Medical Affairs

The Science Behind YTE Modification: Advancing Molecular Design for Extended Therapeutic Effect

FEATURING Rohit K. Katial
  • December 16, 2025
11

GSK US Medical Affairs

Enhancing Biologic Initiation and Adherence in Type 2 Inflammatory Diseases Through Shared Decision Making

FEATURING Diego J. Maselli
  • December 16, 2025